Risk of late cervical cancer screening in the Paris region according to social deprivation and medical densities in daily visited neighborhoods

Objective : To provide background information for strengthening cervical cancer prevention in the Pacific by mapping current human papillomavirus (HPV) vaccination and cervical

Screening history is measured by the percentage of women diagnosed with invasive cervical cancer whose last Pap test was six months to less than three years, three to fi ve years,

In 1999, five international health organizations came to- gether to create the Alliance for Cervical Cancer Prevention (ACCP).* For the next eight years, with support from the

WHO suggests using the following strategy for cervical cancer prevention among women living with HIV: HPV DNA detection in a screen, triage and treat approach starting at the age

This research utilises classification techniques and patient data consisting of known risk factors such as age, the number of pregnancies, STD’s, and smoking habits with the intent

Despite the fact that HPV DNA testing has performance characteris- tics that make it an attractive alternative to cytology as a primary screening method in women over the

To access this association, we 1) collected data from the claim database of the French Health Insurance Fund about the registered family doctors and their enlisted female

The present observational and retrospective study aimed at evaluating the screening rate of cervical cancer between 2006 and 2011 by age, place of location and for 3-years period